EBiSC

EBiSC

Details

EwC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Edelweiss Connect (3 weeks ago)
Dynamic gene expression profiling of the HepaRG™ cell line #HepaRG #invitro #cellculture #BiotechNews See the n… https://t.co/dPow2PDDXK
Edelweiss Connect (3 weeks ago)
RT @barryhardy: Trusted Evidence in Public Health - combining #dataintegrity, #ArtificialIntelligence and #MachineLearning learning in pre…
Edelweiss Connect (5 weeks ago)
Watch our latest #SaferWorldbyDesign panel discussion: In Vitro Biology and Toxicology: Emerging Methods and Best P… https://t.co/cXF7alwRzC
Edelweiss Connect (2 months ago)
RT @DanyX23: Great thread about an interactive notebook I recently made about global inequality, recreating a chart in an article by @MaxCR…
Edelweiss Connect (3 months ago)
RT @LabsExplorer: Tomorrow's webinar >> In Vitro Biology and Toxicology: Emerging Methods and Best Practices - by @edelweissconn https://t…

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA